# EDGAR Filing Document

**Accession Number:** 0000836487
**File Stem:** 0001410368-26-018408
**Filing Date:** 2026-2
**Character Count:** 13032
**Document Hash:** d454065f837560a239b851db0fbdd102
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-26-018408.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 0001410368-26-018408

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260226

**PERIOD START**: 20251231

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MORGAN STANLEY INSTITUTIONAL FUND INC
- **CENTRAL INDEX KEY:** 0000836487

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-05624
- **FILM NUMBER:** 26683230

**BUSINESS ADDRESS:**
- **STREET 1:** 1585 BROADWAY
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 800-548-7786

**MAIL ADDRESS:**
- **STREET 1:** 1585 BROADWAY
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MORGAN STANLEY DEAN WITTER INSTITUTIONAL FUND INC
- **DATE OF NAME CHANGE:** 19990329

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MORGAN STANLEY INSTITUTIONAL FUND INC
- **DATE OF NAME CHANGE:** 19920703

## Series and Classes Contracts Data

### Global Endurance Portfolio (Series ID: S000063049)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000204517 | Class R6     | MSJSX           |
| C000204518 | Class A      | MSJAX           |
| C000204519 | Class C      | MSJCX           |
| C000204520 | Class I      | MSJIX           |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** MORGAN STANLEY INSTITUTIONAL FUND INC

- **b. Investment Company Act file number:** 811-05624

- **c. CIK number of Registrant:** 0000836487

- **d. LEI of Registrant:** 54930067DYRSUSGS4E97

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 1585 Broadway

  - **City:** NEW YORK

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10036

  - **Telephone number:** 800-869-6397

**Item A.2. Information about the Series.**

- **a. Name of Series:** Global Endurance Portfolio

- **b. EDGAR series identifier (if any):** S000063049

- **c. LEI of Series:** 549300V8NT11PW954O87

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-12-31

- **b. Date as of which information is reported:** 2025-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $26014759.23

**Total Liabilities:** $28045.04

**Net Assets:** $25986714.19

**Cash Not Reported:** $20590.78

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000204517 | 1.74%                | 0.49%                | 1.61%                |
| Class ID C000204518 | 1.72%                | 0.45%                | 1.61%                |
| Class ID C000204519 | 1.70%                | 0.36%                | 1.51%                |
| Class ID C000204520 | 1.74%                | 0.49%                | 1.61%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $1391434.38              | $-811020.40                                |
| Month 2  | $389101.63               | $-236960.14                                |
| Month 3  | $-31514.58               | $618103.72                                 |

### Schedule of Portfolio Investments

| Name                               | Title                                                                        | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Appian Corp                        | Appian Corp                                                                  | CUSIP: 03782L101<br>LEI: 529900NIARIFW7HGU386 | Long             | EC               | CORP              | US        |     27312 | NS      | $967391.04    | 3.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbutus Biopharma Corp             | Arbutus Biopharma Corp                                                       | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | CA        |    269347 | NS      | $1295559.07   | 4.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Belite Bio Inc                     | Belite Bio Inc                                                               | CUSIP: 07782B104<br>LEI: 984500BD54036BOEAE79 | Long             | EC               | CORP              | KY        |      7022 | NS      | $1123239.12   | 4.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Calumet Inc                        | Calumet Inc                                                                  | CUSIP: 131428104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51259 | NS      | $1018516.33   | 3.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Carvana Co                         | Carvana Co                                                                   | CUSIP: 146869102<br>LEI: 5493003WEAK2PJ5WS063 | Long             | EC               | CORP              | US        |       809 | NS      | $341414.18    | 1.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Colliers International Group Inc   | Colliers International Group Inc                                             | CUSIP: 194693107<br>LEI: D3O8K13PHLEXXD1DT480 | Long             | EC               | CORP              | CA        |      2198 | NS      | $323127.98    | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Core & Main Inc                    | Core & Main Inc                                                              | CUSIP: 21874C102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6832 | NS      | $355059.04    | 1.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Corpay Inc                         | Corpay Inc                                                                   | CUSIP: 219948106<br>LEI: 549300DG6RR0NQSFLN74 | Long             | EC               | CORP              | US        |      3599 | NS      | $1083047.07   | 4.17%             |  |  |  | No            |                  1 | On Loan: No      |
| EchoStar Corp                      | EchoStar Corp                                                                | CUSIP: 278768106<br>LEI: 549300EE20907QZ9GT38 | Long             | EC               | CORP              | US        |      3081 | NS      | $334904.70    | 1.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Floor & Decor Holdings Inc         | Floor & Decor Holdings Inc                                                   | CUSIP: 339750101<br>LEI: 549300M5FR3N688XGQ36 | Long             | EC               | CORP              | US        |     18411 | NS      | $1121045.79   | 4.31%             |  |  |  | No            |                  1 | On Loan: No      |
| HCA Healthcare Inc                 | HCA Healthcare Inc                                                           | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |      2226 | NS      | $1039230.36   | 4.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                     | Immunovant Inc                                                               | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     53045 | NS      | $1348403.90   | 5.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                         | Insmed Inc                                                                   | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |      3504 | NS      | $609836.16    | 2.35%             |  |  |  | No            |                  1 | On Loan: No      |
| QXO Inc                            | QXO Inc                                                                      | CUSIP: 82846H405<br>LEI: 549300HDXQWWCBOYXP31 | Long             | EC               | CORP              | US        |     78079 | NS      | $1506143.91   | 5.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Teleflex Inc                       | Teleflex Inc                                                                 | CUSIP: 879369106<br>LEI: UUL85LWXB4NGSWWXIQ25 | Long             | EC               | CORP              | US        |     11739 | NS      | $1432627.56   | 5.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Somnigroup International Inc       | Somnigroup International Inc                                                 | CUSIP: 88023U101<br>LEI: 549300HFEKVR3US71V91 | Long             | EC               | CORP              | US        |      9181 | NS      | $819679.68    | 3.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries Ltd                                           | CUSIP: 881624209<br>LEI: 549300BAFGM4RC74ZJ94 | Long             | EC               | CORP              | IL        |     48030 | NS      | $1499016.30   | 5.77%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp           | United Therapeutics Corp                                                     | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      1062 | NS      | $517459.50    | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Morgan Stanley & Co. LLC           | Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio | CUSIP: 61747C525<br>LEI: 549300OJY9IZ31SGS926 | Long             | STIV             | RF                | US        |   2792476 | NS      | $2792476.31   | 10.75%            |  |  |  | No            |                  1 | On Loan: No      |
| Sansan Inc                         | Sansan Inc                                                                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |     39800 | NS      | $440319.11    | 1.69%             |  |  |  | No            |                  2 | On Loan: No      |
| Abivax SA                          | Abivax SA                                                                    | CUSIP: 000000000<br>LEI: 969500D8TMNB184OJU95 | Long             | EC               | CORP              | FR        |     10307 | NS      | $1449114.38   | 5.58%             |  |  |  | No            |                  2 | On Loan: No      |
| Victoria PLC                       | Victoria PLC                                                                 | CUSIP: 000000000<br>LEI: 2138002K6ECECHVCQN25 | Long             | EC               | CORP              | GB        |   3647784 | NS      | $1931769.23   | 7.43%             |  |  |  | No            |                  2 | On Loan: No      |
| Roivant Sciences Ltd               | Roivant Sciences Ltd                                                         | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | BM        |     85745 | NS      | $1860666.50   | 7.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                 | Royalty Pharma PLC                                                           | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |     18739 | NS      | $724074.96    | 2.79%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-01-16

**Name of Applicant:** MORGAN STANLEY INSTITUTIONAL FUND INC

**Signature:** Francis Smith

**Name of Signer:** Francis Smith

**Title:** Principal Financial Officer